Travere Therapeutics, Inc.

TVTX · Healthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…

Travere Therapeutics, Inc. (TVTX), in the Healthcare sector, has 56 disclosed filings on Paydirt over the trailing twelve months from 11 corporate insiders: 0 purchases and 56 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 18. The most active filer was Eric M Dube with 12 filings.

Add to watchlist

Filings, ttm

0 buys · 56 sells

Traders, ttm

11 insiders

Volume, ttmiDollar value disclosed in the window

$102.9M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 17

Filed Sep 17

ADViAverage daily dollar volume

$123.0M

market data

Share price · 12M

$62.76 (+146.8%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $109.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Eric M Dube CHIEF EXECUTIVE OFFICER 12 filings ER

Elizabeth E Reed SVP, GC & CORPORATE SECRETARY 12 filings SC

Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER 9 filings RB

Roy D. Baynes Director 7 filings PH

Peter Heerma EVP, CHIEF COMMERCIAL OFFICER 7 filings WR

William E. Rote SENIOR VICE PRESIDENT, R&D 7 filings CC

Christopher R. Cline CHIEF FINANCIAL OFFICER 6 filings JI

Jula Inrig EVP, Head of R&D & CMO 5 filings

Recent filings

William E. RoteSALE Chief Research Officer $13.1M
208,778 sh across 5 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET Peter HeermaSALE EVP, CHIEF COMMERCIAL OFFICER $17.7M
280,358 sh across 5 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET Jula InrigSALE EVP, Head of R&D & CMO $2.8M
44,274 sh across 3 lots
Exec Sep 15
Filed Sep 17 · 9:33 PM ET Elizabeth E ReedSALE Chief Legal Officer and GC $2.2M
35,800 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 9:32 PM ET Eric M DubeSALE CHIEF EXECUTIVE OFFICER $25.4M
399,730 sh across 7 lots
Exec Sep 15
Filed Sep 17 · 9:31 PM ET Christopher R. ClineSALE CHIEF FINANCIAL OFFICER $3.1M
50,108 sh across 3 lots
Exec Sep 15
Filed Sep 17 · 9:30 PM ET Sandra CalvinSALE SVP, CHIEF ACCOUNTING OFFICER $266K
4,275 sh × $62.13
Exec Sep 15
Filed Sep 17 · 9:29 PM ET Jeffrey A MecklerSALE Director $1.3M
18,800 sh across 3 lots
Exec Sep 10
Filed Sep 11 · 4:05 PM ET Gary A LyonsSALE Director $543K
8,600 sh across 3 lots
Exec Aug 17
Filed Aug 19 · 4:05 PM ET Roy D. BaynesSALE Director $225K
4,500 sh × $50.00
Exec Jun 12
Filed Jun 16 · 5:30 PM ET Timothy CoughlinSALE Director $501K
10,000 sh × $50.07
Exec Jun 12
Filed Jun 16 · 5:30 PM ET Timothy CoughlinSALE Director $141K
3,250 sh × $43.49
Exec May 15
Filed May 19 · 5:30 PM ET Christopher R. ClineSALE CHIEF FINANCIAL OFFICER $102K
2,181 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET Eric M DubeSALE CHIEF EXECUTIVE OFFICER $989K
22,500 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET Peter HeermaSALE CHIEF COMMERCIAL OFFICER $101K
2,174 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET Jula InrigSALE CHIEF MEDICAL OFFICER $1.0M
22,174 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET Elizabeth E ReedSALE Chief Legal Officer and GC $1.0M
22,174 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET William E. RoteSALE Chief Research Officer $121K
2,763 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET Jeffrey A MecklerSALE Director $360K
8,000 sh × $45.00
Exec May 4
Filed May 6 · 5:30 PM ET Roy D. BaynesSALE Director $210K
4,500 sh × $46.65
Exec May 5
Filed May 6 · 5:30 PM ET Roy D. BaynesSALE Director $431K
9,750 sh × $44.22
Exec May 1
Filed May 4 · 5:30 PM ET William E. RoteSALE Chief Research Officer $356K
9,100 sh × $39.09
Exec Apr 22
Filed Apr 23 · 5:30 PM ET Sandra CalvinSALE SVP, CHIEF ACCOUNTING OFFICER $903K
21,977 sh × $41.07
Exec Apr 14
Filed Apr 16 · 5:30 PM ET Roy D. BaynesSALE Director $1.4M
32,750 sh across 2 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET Gary A LyonsSALE Director $329K
8,000 sh × $41.07
Exec Apr 14
Filed Apr 16 · 5:30 PM ET